These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
369 related articles for article (PubMed ID: 19940005)
1. HER2/neu expression correlates with vascular endothelial growth factor-C and lymphangiogenesis in lymph node-positive breast cancer. Schoppmann SF; Tamandl D; Roberts L; Jomrich G; Schoppmann A; Zwrtek R; Dubsky P; Gnant M; Jakesz R; Birner P Ann Oncol; 2010 May; 21(5):955-60. PubMed ID: 19940005 [TBL] [Abstract][Full Text] [Related]
2. Hypoxia inducible factor-1alpha correlates with VEGF-C expression and lymphangiogenesis in breast cancer. Schoppmann SF; Fenzl A; Schindl M; Bachleitner-Hofmann T; Nagy K; Gnant M; Horvat R; Jakesz R; Birner P Breast Cancer Res Treat; 2006 Sep; 99(2):135-41. PubMed ID: 16555123 [TBL] [Abstract][Full Text] [Related]
3. [Relation of lymphatic microvessel density detected by monoclonal antibody D2-40 with VEGF-C expression in breast cancer]. Xie XD; Qu SX; Zheng ZD; Song FL; Liu DW Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):356-60. PubMed ID: 18953835 [TBL] [Abstract][Full Text] [Related]
4. Peritumoral lymphangiogenesis induced by vascular endothelial growth factor C and D promotes lymph node metastasis in breast cancer patients. Zhao YC; Ni XJ; Li Y; Dai M; Yuan ZX; Zhu YY; Luo CY World J Surg Oncol; 2012 Aug; 10():165. PubMed ID: 22906075 [TBL] [Abstract][Full Text] [Related]
5. Clinicopathological significance of lymphangiogenesis and tumor lymphovascular invasion in indonesian breast cancers. Widodo I; Ferronika P; Harijadi A; Triningsih FE; Utoro T; Soeripto Asian Pac J Cancer Prev; 2013; 14(2):997-1001. PubMed ID: 23621275 [TBL] [Abstract][Full Text] [Related]
6. The effect of vascular endothelial growth factor C expression in tumor-associated macrophages on lymphangiogenesis and lymphatic metastasis in breast cancer. Ding M; Fu X; Tan H; Wang R; Chen Z; Ding S Mol Med Rep; 2012 Nov; 6(5):1023-9. PubMed ID: 22923155 [TBL] [Abstract][Full Text] [Related]
7. Lymphatic microvessel density, VEGF-C, and VEGFR-3 expression in different molecular types of breast cancer. Raica M; Cimpean AM; Ceausu R; Ribatti D Anticancer Res; 2011 May; 31(5):1757-64. PubMed ID: 21617236 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab. Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689 [TBL] [Abstract][Full Text] [Related]
9. Hormone receptors and HER2 expression in primary breast carcinoma and corresponding lymph node metastasis: do we need both? Raica M; Cîmpean AM; Ceausu RA; Fulga V; Nica C; Rudico L; Saptefrati L Anticancer Res; 2014 Mar; 34(3):1435-40. PubMed ID: 24596391 [TBL] [Abstract][Full Text] [Related]
10. [Study of the correlation between HER-2 gene and lymphangiogenesis and their prognostic significance in human breast cancer]. Zhang GH; Yang WT; Zhou XY; Zeng Y; Lu HF; Shi DR Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):155-60. PubMed ID: 17425844 [TBL] [Abstract][Full Text] [Related]
11. Lymphangiogenic characteristics of triple negativity in node-negative breast cancer. Liu HT; Ma R; Yang QF; Du G; Zhang CJ Int J Surg Pathol; 2009 Dec; 17(6):426-31. PubMed ID: 19493918 [TBL] [Abstract][Full Text] [Related]
12. [Role of matrix metalloproteinase (MMP)-2 and -9 and vascular endothelial growth factor C in lymph node metastasis of breast cancer]. Zheng SQ; Huang RQ; Zhang YJ Zhonghua Bing Li Xue Za Zhi; 2010 Apr; 39(4):240-4. PubMed ID: 20654122 [TBL] [Abstract][Full Text] [Related]
13. Distinct Characteristics and Metastatic Behaviors of Late Recurrence in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2-negative Breast Cancer: A Single Institute Experience of More Than 10 Years. Chen X; Fan Y; Xu B Clin Breast Cancer; 2018 Dec; 18(6):e1353-e1360. PubMed ID: 30201586 [TBL] [Abstract][Full Text] [Related]
14. Lymphatic vessel density as prognostic factor in breast carcinoma: relation to clinicopathologic parameters. El-Gendi S; Abdel-Hadi M J Egypt Natl Canc Inst; 2009 Jun; 21(2):139-49. PubMed ID: 21057565 [TBL] [Abstract][Full Text] [Related]
15. Influence of neoadjuvant chemotherapy on HER2/neu status in invasive breast cancer. Li P; Liu T; Wang Y; Shao S; Zhang W; Lv Y; Yi J; Wang Z Clin Breast Cancer; 2013 Feb; 13(1):53-60. PubMed ID: 23103368 [TBL] [Abstract][Full Text] [Related]
16. Expression and clinical significance of extracellular matrix protein 1 and vascular endothelial growth factor-C in lymphatic metastasis of human breast cancer. Wu QW; She HQ; Liang J; Huang YF; Yang QM; Yang QL; Zhang ZM BMC Cancer; 2012 Jan; 12():47. PubMed ID: 22284579 [TBL] [Abstract][Full Text] [Related]
17. Expression of vascular endothelial growth factor-C and its receptor in invasive micropapillary carcinoma of the breast. Li YS; Kaneko M; Amatya VJ; Takeshima Y; Arihiro K; Inai K Pathol Int; 2006 May; 56(5):256-61. PubMed ID: 16669874 [TBL] [Abstract][Full Text] [Related]
18. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients. Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190 [TBL] [Abstract][Full Text] [Related]
19. Triple-negative breast cancers: unique clinical presentations and outcomes. Billar JA; Dueck AC; Stucky CC; Gray RJ; Wasif N; Northfelt DW; McCullough AE; Pockaj BA Ann Surg Oncol; 2010 Oct; 17 Suppl 3():384-90. PubMed ID: 20853062 [TBL] [Abstract][Full Text] [Related]
20. Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer. Nakamura Y; Yasuoka H; Tsujimoto M; Yang Q; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K Clin Cancer Res; 2003 Nov; 9(14):5313-7. PubMed ID: 14614015 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]